APA (7th ed.) Citation

An, H., Chen, S., Zhang, X., Ke, S., Ke, J., & Lu, Y. PHF19 before and post induction treatment possess favorable potency of reflecting treatment response to protease inhibitors, event-free survival, and overall survival in multiple myeloma patients. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

An, Hongyu, Shiming Chen, Xin Zhang, Shandong Ke, Jinyong Ke, and Yalan Lu. PHF19 Before and Post Induction Treatment Possess Favorable Potency of Reflecting Treatment Response to Protease Inhibitors, Event-free Survival, and Overall Survival in Multiple Myeloma Patients. Taylor & Francis Group.

MLA (9th ed.) Citation

An, Hongyu, et al. PHF19 Before and Post Induction Treatment Possess Favorable Potency of Reflecting Treatment Response to Protease Inhibitors, Event-free Survival, and Overall Survival in Multiple Myeloma Patients. Taylor & Francis Group.